\n<\/p>\n
Introduction<\/span><\/b>\u00a0<\/span><\/p>\n The\u00a0<\/span>Biosurgery Market<\/span><\/a>\u00a0size is estimated at USD 16.89 billion in 2025, and is expected to reach USD 23.72 billion by 2030, at a CAGR of 7.03% during the forecast period (2025-2030). This growth reflects a steady climb in demand for\u00a0biosurgical\u00a0solutions as hospitals worldwide adopt advanced wound closure, hemostasis, and tissue repair technologies. The rise in surgical complexity, increasing geriatric population\u00a0requiring\u00a0orthopedic and cardiovascular interventions, and growing preference for minimally invasive surgeries are contributing strongly to market expansion. The market\u2019s upward trajectory highlights an increasing emphasis on faster recoveries, reduced hospital stays, and improved post-surgical outcomes, creating robust demand for next-generation biomaterials and\u00a0biosurgical\u00a0systems.<\/span>\u00a0<\/span><\/p>\n Key Trends<\/span><\/b>\u00a0<\/span><\/p>\n Increasing Adoption of Minimally Invasive and Robotic-Assisted Surgeries<\/span><\/b>\u00a0<\/span><\/p>\n One of the most significant trends shaping the biosurgery market is the increasing shift toward minimally invasive procedures (MIS), including laparoscopic and robotic-assisted surgeries. These procedures lead to smaller incisions, less blood loss, shorter hospital stays, and quicker recovery\u00a0times\u00a0 benefits\u00a0that make biosurgery products such as absorbable hemostats, sealants, adhesives, and anti-adhesion barriers essential. As more surgeons and healthcare facilities invest in MIS capabilities, the demand for\u00a0biosurgical\u00a0products compatible with these techniques is growing.<\/span>\u00a0<\/span><\/p>\n Advances in Biomaterials and Biocompatible Solutions<\/span><\/b>\u00a0<\/span><\/p>\n Another clear trend is the increasing use of advanced biomaterials both biologic and synthetic\u00a0 that improve tissue repair, minimize immune response, and support faster healing. Biologic products such as fibrin and collagen matrices remain dominant, but synthetic and semi-synthetic materials are rapidly gaining ground due to improved shelf life, lower logistical constraints, and lower dependency on cold-chain storage.\u00a0<\/span>\u00a0<\/span><\/p>\n Growing Demand from Orthopedic and Cardiovascular Surgeries<\/span><\/b>\u00a0<\/span><\/p>\n The increasing volume of orthopedic surgeries\u00a0\u00a0\u00a0including joint replacements, bone repair, and sports-medicine procedures\u00a0\u00a0\u00a0is driving demand for bone graft substitutes, hemostatic agents, and soft tissue repair solutions. In 2024, orthopedic surgery contributed a significant share of the biosurgery market.<\/span>\u00a0<\/span><\/p>\n Shift Toward Ambulatory and Outpatient Surgical Settings<\/span><\/b>\u00a0<\/span><\/p>\n Hospitals\u00a0remain\u00a0the primary end-user of\u00a0biosurgical\u00a0products, but ambulatory surgical centers (ASCs) are\u00a0emerging\u00a0as a significant growth area. As healthcare systems across the world emphasize cost efficiency and shorter patient stays, outpatient procedures are becoming more common. This shift increases demand for biosurgery solutions designed for quick application, portability, and compatibility with outpatient workflows.<\/span>\u00a0<\/span><\/p>\n Market Segmentation\u00a0<\/span><\/b>\u00a0<\/span><\/p>\n The global biosurgery market can be segmented across several dimensions, including product type, source (material), application, and end user. Key segments include:<\/span>\u00a0<\/span><\/p>\n By Product Type<\/span><\/b>\u00a0<\/span><\/p>\n By Source<\/span><\/b>\u00a0<\/span><\/p>\n By Application<\/span><\/b>\u00a0<\/span><\/p>\n By End User<\/span><\/b>\u00a0<\/span><\/p>\n By Geography<\/span><\/b>\u00a0<\/span><\/p>\n Key Players<\/span><\/b>\u00a0<\/span><\/p>\n The biosurgery market features several established multinational firms that offer a wide range of\u00a0biosurgical\u00a0products and have extensive global distribution networks. These companies\u00a0benefit\u00a0from scale, regulatory experience, and large portfolios spanning bone graft substitutes, sealants, adhesives, and tissue repair products.<\/span>\u00a0<\/span><\/p>\n The competitive landscape\u00a0remains\u00a0moderately\u00a0crowded, yet\u00a0continues evolving as new entrants bring niche solutions and focused biomaterials to surgeons and healthcare providers seeking better healing outcomes and cost-effective care.<\/span>\u00a0<\/span><\/p>\n Conclusion<\/span><\/b>\u00a0<\/span><\/p>\n The biosurgery market is on a solid upward trajectory from 2025 through 2030, as projected by market analysts. The combined impact of increasing surgical volumes\u00a0\u00a0 especially in orthopedics and cardiovascular surgery\u00a0\u00a0 the shift toward minimally invasive and robotic-assisted procedures, and advances in biomaterials are all contributing to this growth.<\/span>\u00a0<\/span><\/p>\n With bone-graft substitutes and biologic materials currently leading market\u00a0share, and\u00a0surgical sealants, adhesives, and synthetic biomaterials gaining momentum, the biosurgery market is diversifying. Demand is rising not only in large hospital settings but also in ambulatory surgical centers and outpatient clinics, reflecting changing healthcare delivery models.<\/span>\u00a0<\/span><\/p>\n Industry related Reports:<\/span><\/b>\u00a0<\/span><\/p>\n Spinal Surgery Market<\/span><\/a>: The Spinal Surgery Market is Segmented by Device Type (Spinal Decompression Devices, and More), Procedure Type (Open Spine Surgery, and Minimally Invasive Spine Surgery), Surgical Technology (Robotic-Assisted Systems, and More), Surgery Setting (Hospitals, and More), Services (Intraoperative Neuromonitoring Services, and More), and Geography (North America, and More).\u00a0<\/span>\u00a0<\/span><\/p>\n Dental Diagnostic And Surgical Market<\/span><\/a>:\u00a0The Dental Diagnostic and Surgical Market is Segmented by Type of Equipment (Dental Systems and Equipment, Dental Lasers, Dental Radiology Equipment, and More), Treatment (Orthodontic, Endodontic, Periodontic, and Prosthodontic), End User (Hospitals, Dental Clinics and More), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa).<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n About Mordor Intelligence:<\/span><\/b>\u00a0<\/span><\/p>\n Mordor Intelligence is a trusted partner for businesses\u00a0seeking\u00a0comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.<\/span>\u00a0<\/span><\/p>\n With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence\u00a0possesses\u00a0a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.<\/span>\u00a0<\/span><\/p>\n For any inquiries or to access the full report, please contact:<\/span><\/b>\u00a0<\/span><\/p>\n media@mordorintelligence.com<\/span><\/a>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\nhttps:\/\/www.mordorintelligence.com\/<\/span><\/a>\u00a0<\/span><\/p>\n